Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for preventing severe COVID-19 progression
NCT04419025Phase 2Completed
- Sponsor
- Cambridge Health Alliance
- Start
- Sep 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in coronavirus disease 2019 (COVID-19), sponsored by Cambridge Health Alliance. Started Sep 2020; status: completed.
02
Drugs
acetylcysteine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04419025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04419025.